Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $2.49, $0.34 better than the analyst estimate of $2.15. Revenue for the quarter came in at $8 billion versus the consensus estimate of $6.74 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2022 EPS of $8.50-$8.65, versus the consensus of $7.54.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.